Adaptation of acute lymphoblastic leukemia (ALL) to the post-transplant allogeneic environment.
|
University of Rochester / Craig Mullen |
Innovation Grants |
2009 |
New York |
Linking mitogenic sonic hedgehog signaling to the oncogene Yap 1 in neural stem/progenitor cells and medulloblastoma.
|
Memorial Sloan-Kettering Cancer Center / Anna Kenney, PhD |
Innovation Grants |
2009 |
New York |
WWOX as a Signal Mediator in Pediatric Osteosarcoma |
The Ohio State University / Rami Aqeilan |
'A' Award Grants |
2009 |
Ohio |
Effects of CNS Treatment on the Hippocampus |
University of Arizona / Ki Moore |
Nurse Researcher Grants |
2009 |
Arizona |
Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).
|
University of California San Francisco / Michelle Hermiston, MD, PhD |
Young Investigator Grants |
2009 |
California |
Metabolic control of p53 activation in T-ALL.
|
Duke University / Jeffrey Rathmell |
Innovation Grants |
2009 |
North Carolina |
GSTM4, a novel target for treating Ewing sarcoma.
|
Huntsman Cancer Institute / Wen Luo |
Young Investigator Grants |
2009 |
Utah |
Identification of proteins interacting with ALK in neuroblastoma.
|
Dana-Farber Cancer Institute / Rani George |
Young Investigator Grants |
2009 |
Massachusetts |
DFMO-based combination therapy for the treatment of advanced stage neuroblastoma.
|
Cancer Research Center of Hawaii / Dana-Lynn Koomoa |
Young Investigator Grants |
2009 |
Hawaii |
Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2009 |
Colorado |